1. Home
  2. WHWK vs ASRT Comparison

WHWK vs ASRT Comparison

Compare WHWK & ASRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WHWK
  • ASRT
  • Stock Information
  • Founded
  • WHWK 2007
  • ASRT 1995
  • Country
  • WHWK United States
  • ASRT United States
  • Employees
  • WHWK N/A
  • ASRT N/A
  • Industry
  • WHWK Biotechnology: Pharmaceutical Preparations
  • ASRT Biotechnology: Pharmaceutical Preparations
  • Sector
  • WHWK Health Care
  • ASRT Health Care
  • Exchange
  • WHWK Nasdaq
  • ASRT Nasdaq
  • Market Cap
  • WHWK 48.3M
  • ASRT 57.9M
  • IPO Year
  • WHWK N/A
  • ASRT 1997
  • Fundamental
  • Price
  • WHWK $1.87
  • ASRT $0.66
  • Analyst Decision
  • WHWK
  • ASRT Strong Buy
  • Analyst Count
  • WHWK 0
  • ASRT 2
  • Target Price
  • WHWK N/A
  • ASRT $3.25
  • AVG Volume (30 Days)
  • WHWK 100.5K
  • ASRT 220.5K
  • Earning Date
  • WHWK 05-08-2025
  • ASRT 05-12-2025
  • Dividend Yield
  • WHWK N/A
  • ASRT N/A
  • EPS Growth
  • WHWK N/A
  • ASRT N/A
  • EPS
  • WHWK 0.91
  • ASRT N/A
  • Revenue
  • WHWK $27,775,000.00
  • ASRT $119,001,000.00
  • Revenue This Year
  • WHWK $40.15
  • ASRT N/A
  • Revenue Next Year
  • WHWK N/A
  • ASRT $11.71
  • P/E Ratio
  • WHWK $2.01
  • ASRT N/A
  • Revenue Growth
  • WHWK 16.51
  • ASRT N/A
  • 52 Week Low
  • WHWK $1.21
  • ASRT $0.51
  • 52 Week High
  • WHWK $3.81
  • ASRT $1.80
  • Technical
  • Relative Strength Index (RSI)
  • WHWK N/A
  • ASRT 50.02
  • Support Level
  • WHWK N/A
  • ASRT $0.65
  • Resistance Level
  • WHWK N/A
  • ASRT $0.71
  • Average True Range (ATR)
  • WHWK 0.00
  • ASRT 0.03
  • MACD
  • WHWK 0.00
  • ASRT -0.00
  • Stochastic Oscillator
  • WHWK 0.00
  • ASRT 13.11

About ASRT Assertio Holdings Inc.

Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older and Zipsor, liquid-filled capsules for relief of mild to moderate pain.

Share on Social Networks: